Gold, L.S., Lebwohl, M.G., Bhatia, N., Lin, T. and Pillai, R. 2019. Long-Term Management of Moderate-to-Severe Plaque Psoriasis: Maintenance of Treatment Success Following Cessation of Fixed Combination Halobetasol Propionate 0.01% And Tazarotene 0.045% (HP/TAZ) Lotion. SKIN The Journal of Cutaneous Medicine. 3, (Nov. 2019), S31. DOI:https://doi.org/10.25251/skin.3.supp.31.